DENTSPLY SIRONA Inc. [NASDAQ: XRAY] closed the trading session at $48.34 on 10/22/20. The day’s price range saw the stock hit a low of $46.88, while the highest price level was $50.44. The company report on October 13, 2020 that Dentsply Sirona to Host Third Quarter 2020 Conference Call on November 5th.
DENTSPLY SIRONA Inc. (NASDAQ:XRAY), The Dental Solutions Company™, today announced that the Company will host an investor conference call and live webcast on Thursday, November 5, 2020 at 8:30 am ET and send out an earnings press release earlier that morning. A presentation related to the call will be available on www.dentsplysirona.com in the Investors section.
Get 12 free stock market lessons delivered to your email from Investor's Business Daily, the leader in investing education for over 35 years. We’ll cover the basics of better investing and show you how to give yourself an edge in the market.
GET FREE LESSON outside the norm.
Conference Call/Webcast Information.
The stocks have a year to date performance of -14.58 percent and weekly performance of 6.48 percent. The stock has been moved at 22.97 percent over the last six months. The stock has performed 13.13 percent around the most recent 30 days and changed 11.79 percent over the most recent 3-months.
If compared to the average trading volume of 1.35M shares, XRAY reached to a volume of 2425617 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about DENTSPLY SIRONA Inc. [XRAY]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for XRAY shares is $49.38 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on XRAY stock is a recommendation set at 2.10. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Guggenheim have made an estimate for DENTSPLY SIRONA Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on October 22, 2020. While these analysts kept the previous recommendation, H.C. Wainwright dropped their target price from $50 to $45. The new note on the price target was released on August 10, 2020, representing the official price target for DENTSPLY SIRONA Inc. stock. Previously, the target price had yet another raise to $51, while Piper Sandler analysts kept a Overweight rating on XRAY stock. On June 15, 2020, analysts increased their price target for XRAY shares from 38 to 50.
The Average True Range (ATR) for DENTSPLY SIRONA Inc. is set at 1.54, with the Price to Sales ratio for XRAY stock in the period of the last 12 months amounting to 3.05. The Price to Book ratio for the last quarter was 2.28, with the Price to Cash per share for the same quarter was set at 5.11. Price to Free Cash Flow for XRAY in the course of the last twelve months was 23.92 with Quick ratio for the last quarter at 2.40.
XRAY stock trade performance evaluation
DENTSPLY SIRONA Inc. [XRAY] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 6.48. With this latest performance, XRAY shares gained by 13.13% in over the last four-week period, additionally plugging by 22.97% over the last 6 months – not to mention a drop of -11.14% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for XRAY stock in for the last two-week period is set at 65.83, with the RSI for the last a single of trading hit 71.25, and the three-weeks RSI is set at 61.45 for DENTSPLY SIRONA Inc. [XRAY]. The present Moving Average for the last 50 days of trading for this stock 44.59, while it was recorded at 45.80 for the last single week of trading, and 45.46 for the last 200 days.
DENTSPLY SIRONA Inc. [XRAY]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and DENTSPLY SIRONA Inc. [XRAY] shares currently have an operating margin of +10.94 and a Gross Margin at +53.71. DENTSPLY SIRONA Inc.’s Net Margin is presently recorded at +6.52.
Return on Total Capital for XRAY is now 6.54, given the latest momentum, and Return on Invested Capital for the company is 3.94. Return on Equity for this stock inclined to 5.15, with Return on Assets sitting at 3.04. When it comes to the capital structure of this company, DENTSPLY SIRONA Inc. [XRAY] has a Total Debt to Total Equity ratio set at 31.39. Additionally, XRAY Total Debt to Total Capital is recorded at 23.89, with Total Debt to Total Assets ending up at 18.58. Long-Term Debt to Equity for the company is recorded at 30.49, with the Long-Term Debt to Total Capital now at 23.20.
Reflecting on the efficiency of the workforce at the company, DENTSPLY SIRONA Inc. [XRAY] managed to generate an average of $17,296 per employee. Receivables Turnover for the company is 5.43 with a Total Asset Turnover recorded at a value of 0.47.DENTSPLY SIRONA Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.40 and a Current Ratio set at 3.10.
Earnings per share (EPS) analysis for DENTSPLY SIRONA Inc. [XRAY] stock
With the latest financial reports released by the company, DENTSPLY SIRONA Inc. posted 0.57/share EPS, while the average EPS was predicted by analysts to be reported at 0.5/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 14.00%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for XRAY. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for DENTSPLY SIRONA Inc. go to 4.27%.
DENTSPLY SIRONA Inc. [XRAY]: Insider Ownership positions
There are presently around $10,370 million, or 95.95% of XRAY stock, in the hands of institutional investors. The top three institutional holders of XRAY stocks are: VANGUARD GROUP INC with ownership of 25,114,918, which is approximately -4.51% of the company’s market cap and around 0.30% of the total institutional ownership; GENERATION INVESTMENT MANAGEMENT LLP, holding 19,264,168 shares of the stock with an approximate value of $931.23 million in XRAY stocks shares; and BLACKROCK INC., currently with $782.54 million in XRAY stock with ownership of nearly 2.33% of the company’s market capitalization.
Positions in DENTSPLY SIRONA Inc. stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 225 institutional holders increased their position in DENTSPLY SIRONA Inc. [NASDAQ:XRAY] by around 21,837,167 shares. Additionally, 275 investors decreased positions by around 18,691,332 shares, while 74 investors held positions by with 173,986,618 shares. The mentioned changes placed institutional holdings at 214,515,117 shares, according to the latest SEC report filing. XRAY stock had 66 new institutional investments in for a total of 5,516,065 shares, while 73 institutional investors sold positions of 4,490,692 shares during the same period.